CombiChemLab.com - A free online information source for Drug Discovery, Combinatorial Chemistry, High Throughput Synthesis, High and Ultra-High Throughput Screening and Lab Automation.

News Highlights:

Semafore to Present at BIO CEO & Investor Conference.

arGentis Pharmaceuticals' ARG201 receives orphan drug designation.

Eli Lilly to discontinue Humatin (Paromomycin Sulfate capsules).

Merck to pay over $650M to settle US drug pricing probe.

BioNumerik begins global Phase III ovarian cancer trial on novel anticancer drug candidate Karenitecin®.

Human Genome Sciences and Xencor sign antibody collaboration.

PPD Inc. to acquire InnoPharm Ltd.

Illumina Sequences the First African Human Genome.

Idera Pharmaceuticals Inc. gest OK to license two lead drug candidates to Merck.

Meditrina Pharmaceuticals Inc. announces exclusive global license agreement with AstraZeneca.

Guava Technologies celebrates 10th anniversary.

Takeda Pharmaceuticals Co. buys Amgen's Japan arm and the commercial rights to 13 Amgen's experimental drugs for up to $902 M.

FDA grants orphan drug status for novel Akt inhibitor VQD-002 in multiple myeloma.

ZIOPHARM Oncology Inc. initiates treatment of first patients in two separate Phase I/II combination studies of both Indibulin and Palifosfamide.

Collaboration between Genzyme Corp. and Isis Pharmaceuticals Inc. gets clearance.

Thomson Instrument has been added to the High-Throughput Purification Systems here at CombiChemLab.com

Last Update: 02/10/2008